Clinical Trial Update: Effects of Intranasal Oxytocin on Cigarette Smoking [Phase 4]

View source ↗

Summary

Phase 4 clinical trial assessing intranasal oxytocin for nicotine dependence and tobacco smoking has completed with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Nicotine Dependence
• Tobacco Use Disorder

Drugs mentioned

• intranasal oxytocin (oxytocin)

Snippet

Sponsor: University of Southern California | Conditions: Nicotine Dependence, Tobacco Smoking | Phase 4 | Status: COMPLETED | Results posted: 2021-11-15